Longitudinal analysis reveals myeloid cell contributions to murine neuroPASC pathogenesis.
Paper
Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC
The paper is loaded when this pane is shown.
The authors' code
License · 201 lines · 11 KB · Apache-2.0
- Apache License
- Version 2.0, January 2004
- http://www.apache.org/licenses/
- TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION
- 1. Definitions.
- "License" shall mean the terms and conditions for use, reproduction,
- and distribution as defined by Sections 1 through 9 of this document.
- "Licensor" shall mean the copyright owner or entity authorized by
- the copyright owner that is granting the License.
- "Legal Entity" shall mean the union of the acting entity and all
- other entities that control, are controlled by, or are under common
- control with that entity. For the purposes of this definition,
- "control" means (i) the power, direct or indirect, to cause the
- direction or management of such entity, whether by contract or
- otherwise, or (ii) ownership of fifty percent (50%) or more of the
- outstanding shares, or (iii) beneficial ownership of such entity.
- "You" (or "Your") shall mean an individual or Legal Entity
- exercising permissions granted by this License.
- "Source" form shall mean the preferred form for making modifications,
- including but not limited to software source code, documentation
- source, and configuration files.
- "Object" form shall mean any form resulting from mechanical
- transformation or translation of a Source form, including but
- not limited to compiled object code, generated documentation,
- and conversions to other media types.
- "Work" shall mean the work of authorship, whether in Source or
- Object form, made available under the License, as indicated by a
- copyright notice that is included in or attached to the work
- (an example is provided in the Appendix below).
- "Derivative Works" shall mean any work, whether in Source or Object
- form, that is based on (or derived from) the Work and for which the
- editorial revisions, annotations, elaborations, or other modifications
- represent, as a whole, an original work of authorship. For the purposes
- of this License, Derivative Works shall not include works that remain
- separable from, or merely link (or bind by name) to the interfaces of,
- the Work and Derivative Works thereof.
- "Contribution" shall mean any work of authorship, including
- the original version of the Work and any modifications or additions
- to that Work or Derivative Works thereof, that is intentionally
- submitted to Licensor for inclusion in the Work by the copyright owner
- or by an individual or Legal Entity authorized to submit on behalf of
- the copyright owner. For the purposes of this definition, "submitted"
- means any form of electronic, verbal, or written communication sent
- to the Licensor or its representatives, including but not limited to
- communication on electronic mailing lists, source code control systems,
- and issue tracking systems that are managed by, or on behalf of, the
- Licensor for the purpose of discussing and improving the Work, but
- excluding communication that is conspicuously marked or otherwise
- designated in writing by the copyright owner as "Not a Contribution."
- "Contributor" shall mean Licensor and any individual or Legal Entity
- on behalf of whom a Contribution has been received by Licensor and
- subsequently incorporated within the Work.
- 2. Grant of Copyright License. Subject to the terms and conditions of
- this License, each Contributor hereby grants to You a perpetual,
- worldwide, non-exclusive, no-charge, royalty-free, irrevocable
- copyright license to reproduce, prepare Derivative Works of,
- publicly display, publicly perform, sublicense, and distribute the
- Work and such Derivative Works in Source or Object form.
- 3. Grant of Patent License. Subject to the terms and conditions of
- this License, each Contributor hereby grants to You a perpetual,
- worldwide, non-exclusive, no-charge, royalty-free, irrevocable
- (except as stated in this section) patent license to make, have made,
- use, offer to sell, sell, import, and otherwise transfer the Work,
- where such license applies only to those patent claims licensable
- by such Contributor that are necessarily infringed by their
- Contribution(s) alone or by combination of their Contribution(s)
- with the Work to which such Contribution(s) was submitted. If You
- institute patent litigation against any entity (including a
- cross-claim or counterclaim in a lawsuit) alleging that the Work
- or a Contribution incorporated within the Work constitutes direct
- or contributory patent infringement, then any patent licenses
- granted to You under this License for that Work shall terminate
- as of the date such litigation is filed.
- 4. Redistribution. You may reproduce and distribute copies of the
- Work or Derivative Works thereof in any medium, with or without
- modifications, and in Source or Object form, provided that You
- meet the following conditions:
- (a) You must give any other recipients of the Work or
- Derivative Works a copy of this License; and
- (b) You must cause any modified files to carry prominent notices
- stating that You changed the files; and
- (c) You must retain, in the Source form of any Derivative Works
- that You distribute, all copyright, patent, trademark, and
- attribution notices from the Source form of the Work,
- excluding those notices that do not pertain to any part of
- the Derivative Works; and
- (d) If the Work includes a "NOTICE" text file as part of its
- distribution, then any Derivative Works that You distribute must
- include a readable copy of the attribution notices contained
- within such NOTICE file, excluding those notices that do not
- pertain to any part of the Derivative Works, in at least one
- of the following places: within a NOTICE text file distributed
- as part of the Derivative Works; within the Source form or
- documentation, if provided along with the Derivative Works; or,
- within a display generated by the Derivative Works, if and
- wherever such third-party notices normally appear. The contents
- of the NOTICE file are for informational purposes only and
- do not modify the License. You may add Your own attribution
- notices within Derivative Works that You distribute, alongside
- or as an addendum to the NOTICE text from the Work, provided
- that such additional attribution notices cannot be construed
- as modifying the License.
- You may add Your own copyright statement to Your modifications and
- may provide additional or different license terms and conditions
- for use, reproduction, or distribution of Your modifications, or
- for any such Derivative Works as a whole, provided Your use,
- reproduction, and distribution of the Work otherwise complies with
- the conditions stated in this License.
- 5. Submission of Contributions. Unless You explicitly state otherwise,
- any Contribution intentionally submitted for inclusion in the Work
- by You to the Licensor shall be under the terms and conditions of
- this License, without any additional terms or conditions.
- Notwithstanding the above, nothing herein shall supersede or modify
- the terms of any separate license agreement you may have executed
- with Licensor regarding such Contributions.
- 6. Trademarks. This License does not grant permission to use the trade
- names, trademarks, service marks, or product names of the Licensor,
- except as required for reasonable and customary use in describing the
- origin of the Work and reproducing the content of the NOTICE file.
- 7. Disclaimer of Warranty. Unless required by applicable law or
- agreed to in writing, Licensor provides the Work (and each
- Contributor provides its Contributions) on an "AS IS" BASIS,
- WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or
- implied, including, without limitation, any warranties or conditions
- of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A
- PARTICULAR PURPOSE. You are solely responsible for determining the
- appropriateness of using or redistributing the Work and assume any
- risks associated with Your exercise of permissions under this License.
- 8. Limitation of Liability. In no event and under no legal theory,
- whether in tort (including negligence), contract, or otherwise,
- unless required by applicable law (such as deliberate and grossly
- negligent acts) or agreed to in writing, shall any Contributor be
- liable to You for damages, including any direct, indirect, special,
- incidental, or consequential damages of any character arising as a
- result of this License or out of the use or inability to use the
- Work (including but not limited to damages for loss of goodwill,
- work stoppage, computer failure or malfunction, or any and all
- other commercial damages or losses), even if such Contributor
- has been advised of the possibility of such damages.
- 9. Accepting Warranty or Additional Liability. While redistributing
- the Work or Derivative Works thereof, You may choose to offer,
- and charge a fee for, acceptance of support, warranty, indemnity,
- or other liability obligations and/or rights consistent with this
- License. However, in accepting such obligations, You may act only
- on Your own behalf and on Your sole responsibility, not on behalf
- of any other Contributor, and only if You agree to indemnify,
- defend, and hold each Contributor harmless for any liability
- incurred by, or claims asserted against, such Contributor by reason
- of your accepting any such warranty or additional liability.
- END OF TERMS AND CONDITIONS
- APPENDIX: How to apply the Apache License to your work.
- To apply the Apache License to your work, attach the following
- boilerplate notice, with the fields enclosed by brackets "[]"
- replaced with your own identifying information. (Don't include
- the brackets!) The text should be enclosed in the appropriate
- comment syntax for the file format. We also recommend that a
- file or class name and description of purpose be included on the
- same "printed page" as the copyright notice for easier
- identification within third-party archives.
- Copyright [yyyy] [name of copyright owner]
- Licensed under the Apache License, Version 2.0 (the "License");
- you may not use this file except in compliance with the License.
- You may obtain a copy of the License at
- http://www.apache.org/licenses/LICENSE-2.0
- Unless required by applicable law or agreed to in writing, software
- distributed under the License is distributed on an "AS IS" BASIS,
- WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
- See the License for the specific language governing permissions and
- limitations under the License.
LICENSE at commit 9b7d007, under Apache-2.0 · at the source
Overview
- Department of Microbiology and Immunology, University of Iowa,Iowa City, IA USA
- Department of Internal Medicine, University of Iowa,Iowa City, IA USA
- Department of Medicine, Washington University School of Medicine,St. Louis, MO USA
- Department of Pathology, University of Iowa,Iowa City, IA USA
- Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine,Shanghai, China
- Singapore Immunology Network, Agency for Science, Technology and Research,Singapore, Singapore
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Repository
Its files are read in the Code ↔ Paper reader above.
lutan3/neuroPASC-scRNA-seq-data-analysis
9b7d0070337a978337e930343a5d05899a52b3c0, 4 June 2026Availability: 1 check, the latest on 27 September 2026: the link answers
- 27 September 2026: the link answers
Code availability statement
The paper has a code availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it points to the authors' code: lutan3/
neuroPASC-scRNA-seq-data -analysis
Read it in the paper: doi.org/10.1038/s41467-026-76156-5.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
Datasets cited
- bioproject:PRJNA1368667, at NCBI BioProject; found in “Data availability”
- geo:GSE338411, at NCBI GEO; found in “Data availability”
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it points to 2 datasets: NCBI BioProject PRJNA1368667, NCBI GEO GSE338411
Read it in the paper: doi.org/10.1038/s41467-026-76156-5.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 2 keywords, 17 MeSH terms, 1 funder, 99 references.
Cite
This paper
Tan, L., Verma, A. K., Lowery, S., Thurman, A., Sariol, A., Fain, C., Liu, Z., Ginhoux, F., Harty, J., Meyerholz, D. K., & Perlman, S. (2026). Longitudinal analysis reveals myeloid cell contributions to murine neuroPASC pathogenesis. Nature communications, 17(1), 9259. https://
BibTeX
@article{tan2026longitud
author = {Tan, Lu and Verma, Abhishek K. and Lowery, Shea and Thurman, Andrew and Sariol, Alan and Fain, Cori and Liu, Zhaoyuan and Ginhoux, Florent and Harty, John and Meyerholz, David K. and Perlman, Stanley},
title = {{Longitudinal analysis reveals myeloid cell contributions to murine neuroPASC pathogenesis}},
journal = {Nature communications},
year = {2026},
month = jul,
volume = {17},
number = {1},
pages = {9259},
publisher = {Nature Portfolio},
issn = {2041-1723},
doi = {10.1038/
url = {https://
pmid = {42669720},
pmcid = {PMC13527130}
}
RIS
TY - JOUR
AU - Tan, Lu
AU - Verma, Abhishek K.
AU - Lowery, Shea
AU - Thurman, Andrew
AU - Sariol, Alan
AU - Fain, Cori
AU - Liu, Zhaoyuan
AU - Ginhoux, Florent
AU - Harty, John
AU - Meyerholz, David K.
AU - Perlman, Stanley
TI - Longitudinal analysis reveals myeloid cell contributions to murine neuroPASC pathogenesis
T2 - Nature communications
J2 - Nat Commun
PY - 2026
DA - 2026/
VL - 17
IS - 1
SP - 9259
SN - 2041-1723
PB - Nature Portfolio
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "Longitudinal analysis reveals myeloid cell contributions to murine neuroPASC pathogenesis",
"container-title": "Nature communications",
"author": [
{
"family": "Tan",
"given": "Lu"
},
{
"family": "Verma",
"given": "Abhishek K."
},
{
"family": "Lowery",
"given": "Shea"
},
{
"family": "Thurman",
"given": "Andrew"
},
{
"family": "Sariol",
"given": "Alan"
},
{
"family": "Fain",
"given": "Cori"
},
{
"family": "Liu",
"given": "Zhaoyuan"
},
{
"family": "Ginhoux",
"given": "Florent"
},
{
"family": "Harty",
"given": "John"
},
{
"family": "Meyerholz",
"given": "David K."
},
{
"family": "Perlman",
"given": "Stanley"
}
],
"container-title-short":
"volume": "17",
"issue": "1",
"page": "9259",
"DOI": "10.1038/
"PMID": "42669720",
"PMCID": "PMC13527130",
"ISSN": "2041-1723",
"publisher": "Nature Portfolio",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
30
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1073/pnas.2530209123
- Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: other condition, mouse, 13 references, 3 authors
- [2] doi:10.1038/s41467-025-62048-7 [code]
- Hamsters with long COVID present distinct transcriptomic profiles associated with neurodegenerative processes in brainstem.Journal: Nature communicationsIn common: other condition, cellular / molecular, 9 references
- [3] doi:10.1038/s44318-025-00625-8
- Microglial colonization of the developing mouse brain is controlled by both microglial and neural CSF-1.Journal: The EMBO journalIn common: mouse, cellular / molecular, 6 references, author Florent Ginhoux
- [4] doi:10.1038/s41467-024-49908-4 [code]
- CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice.Journal: Nature communicationsIn common: mouse, cellular / molecular, 9 references
- [5] doi:10.1038/s41586-024-07873-4
- Fibrin drives thromboinflammation and neuropathology in COVID-19.Journal: NatureIn common: other condition, mouse, cellular / molecular, 7 references
- [6] doi:10.3389/fimmu.2026.1776555 [code]
- Multi-omics analysis of long COVID (post-COVID-19 condition) reveals persistent mitochondrial dysfunction, suppressed oxidative phosphorylation, and immune dysregulation.Journal: Frontiers in immunologyIn common: other condition, cellular / molecular, 6 references
- [7] doi:10.1038/s41593-025-01871-z [code]
- Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19.Journal: Nature neuroscienceIn common: other condition, cellular / molecular, 7 references
- [8] doi:10.1093/brain/awae031
- Engineered Wnt7a ligands rescue blood-brain barrier and cognitive deficits in a COVID-19 mouse model.Journal: Brain : a journal of neurologyIn common: other condition, mouse, cellular / molecular, 6 references
- [9] doi:10.1016/j.xcrm.2024.101561 [code]
- Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment.Journal: Cell reports. MedicineIn common: other condition, 7 references
- [10] doi:10.1186/s12974-026-03751-0
- Spatial multiomics dissects the SARS-CoV-2-induced disruption of cell adhesion and immune dynamics in the human hippocampus.Journal: Journal of neuroinflammationIn common: other condition, cellular / molecular, 6 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:29ac7ee798725920…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1038/s41467-026-76156-5)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1038/s41467-026-76156-5.svg
:target: https://openscicode.org/badge/doi/10.1038/s41467-026-76156-5
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1038/s41467-026-76156-5"><img src="https://openscicode.org/badge/doi/10.1038/s41467-026-76156-5.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".
If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
